Roger M. Klein - 06 Nov 2025 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Reporting relationship: 10%+ Owner
Issuer ticker: EVOK
Reported as of: 06 Nov 2025
Net transaction value: -$95,885
SEC form: 4
Accepted by SEC: 07 Nov 2025, 16:58:59 UTC
Prior SEC filing: 06 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Roger Klein

Key filing fact

Roger M. Klein filed Form 4 for Evoke Pharma Inc (EVOK) on 07 Nov 2025.

Key facts

This page summarizes Roger M. Klein's Form 4 filing for Evoke Pharma Inc (EVOK).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Nov 2025, 16:58.

Change

Previous filing in this sequence was filed on 06 Nov 2025.
Current net transaction value: -$95,885.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001651175 Primary reporting owner

Klein Roger M.

Relationship: 10%+ Owner
Address: C/O CHOATE, HALL & STEWART, TWO INTERNATIONAL PLACE, BOSTON
Signature: /s/ Roger Klein
Signature date: 07 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVOK transaction

Common Stock

Sale

Transaction value: $53,285
Shares: -5,000
Change %: -15%
Price: $10.66
Shares after: 29,000
Date: 06 Nov 2025
Ownership: By IRA
Footnotes: F1, F2

EVOK transaction

Common Stock

Sale

Transaction value: $42,600
Shares: -4,000
Change %: -3.1%
Price: $10.65
Shares after: 125,000
Date: 06 Nov 2025
Ownership: By Krieger Charitable Trust
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Roger M. Klein is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Price reflects the weighted average sale price for the shares, which were sold in multiple transactions at prices that ranged from $10.65 to $10.66. Upon request, the Reporting Person will provide information regarding the number of shares sold at each price within the range to the Issuer, any security holder of the issuer, or the SEC staff.

Footnote F2

Represents securities of the Issuer owned directly by Mr. Klein's Roth Individual Retirement Account ("IRA").

Footnote F3

Represents securities of the Issuer owned directly by Krieger Charitable Trust (the "Trust"). Mr. Klein, as sole trustee of the Trust, may be deemed to beneficially own the securities of the Issuer owned directly by the Trust. Mr. Klein disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Mr. Klein is a beneficial owner of the securities of the Issuer reported herein.